The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas (NF110)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04283669
Recruitment Status : Active, not recruiting
First Posted : February 25, 2020
Last Update Posted : September 11, 2023
Memorial Sloan Kettering Cancer Center
Information provided by (Responsible Party):
Bruce Korf, MD, University of Alabama at Birmingham

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 18, 2025
Estimated Study Completion Date : December 31, 2025